Subscribe to RSS
DOI: 10.1055/s-2006-925116
Plasma Glucose-lowering Action of Hon-Chi in Streptozotocin-induced Diabetic Rats
Publication History
Received 11 August 2005
Accepted after revision 3 November 2005
Publication Date:
08 March 2006 (online)
Abstract
Hon-Chi was used for anti-hyperglycemic activity screening in streptozotocin-induced diabetic rats (STZ-diabetic rats) in an attempt to develop new substances for handling diabetes. Mandarin Hon-Chi is red yeast rice fermented with Monascus pilous and Monascus purpureus. Single oral administration of Hon-Chi decreased plasma glucose in STZ-diabetic rats in a dose-dependent manner from 50 mg/kg to 350 mg/kg. Similar treatment with Hon-Chi also lowered the plasma glucose in normal rats as effectively as that produced in STZ-diabetic rats. In addition, oral administration of Hon-Chi at the highest dose (350 mg/kg) attenuated the elevation of plasma glucose induced by an intravenous glucose challenge test in normal rats. Moreover, mRNA levels of phosphoenolpyruvate carboxykinase (PEPCK) in liver from STZ-diabetic rats were reversed in a dose-dependent manner by the repeated oral treatment of Hon-Chi three times daily for two weeks. Otherwise, hyperphagia in STZ-diabetic rats was markedly reversed by similar repeated treatment of Hon-Chi. The obtained results suggest that oral administration of Hon-Chi could decrease hepatic gluconeogenesis to lower plasma glucose in diabetic rats lacking insulin.
Key words
Intravenous glucose challenge test - phosphoenolpyruvate carboxykinase - Hon-Chi - streptozotocin-induced diabetic rats
References
- 1 Harris S B, Lank C N. Recommendations from the Canadian Diabetes Association. 2003 guidelines for prevention and management of diabetes and related cardiovascular risk factors. Can Fam Physician. 2004; 50 425-433
- 2 Jeffcoate S L. Diabetes control and complications: the role of glycated haemoglobin, 25 years on. Diabet Med. 2004; 21 657-665
- 3 Lindstrom J, Louheranta A, Mannelin M, Rastas M, Salminen V, Eriksson J, Uusitupa M, Tuomilehto J. Finnish Diabetes Prevention Study Group. The Finnish Diabetes Prevention Study (DPS): Lifestyle intervention and 3-year results on diet and physical activity. Diabetes Care. 2003; 26 3230-3236
- 4 Journoud M, Jones P J. Red yeast rice: a new hypolipidemic drug. Life Sci. 2004; 74 2675-2683
- 5 Viana A Y, Oshida Y, Han Y Q, Koshinaka K, Sato Y. Effects of imidapril, an angiotensin-converting enzyme inhibitor, on insulin sensitivity and responsiveness in streptozotocin-induced diabetic rats. Horm Metab Res. 2004; 36 34-38
-
6 Nebendahl K.
Routes of administration. In: Krinke GJ (ed) The laboratory rat. London; Academic press 2000: 463-483 - 7 Johansen O, Vaaler S, Jorde R, Reikeras O. Increased plasma glucose levels after Hypnorm anaesthesia, but not after Pentobarbital anaesthesia in rats. Lab Anim. 1994; 28 244-248
- 8 Liu I M, Chi T C, Hsu F L, Chen C F, Cheng J T. Isoferulic acid as active principle from the rhizoma of Cimicifuga dahurica to lower plasma glucose in diabetic rats. Planta Med. 1999; 65 712-714
- 9 Cefalu W T. Evolving strategies for insulin delivery and therapy. Drugs. 2004; 64 1149-1161
- 10 Wohaieb S A, Godin D V. Alterations in free radical tissue-defense mechanisms in streptozotocin-induced diabetes in rat. Effect of insulin treatment. Diabetes. 1987; 36 1014-1018
- 11 Chavez M, Seeley R J, Havel P J, Friedman M I, Matson C A, Woods S C, Schwartz M W. Effect of a high-fat diet on food intake and hypothalamic neuropeptide gene expression in streptozotocin diabetes. J Clin Invest. 1998; 102 340-346
- 12 Bessesen D H. The role of carbohydrates in insulin resistance. J Nutr. 2001; 131 S2782-S2786
- 13 Bollen M, Keppens S, Stalmans W. Specific features of glycogen metabolism in the liver. Biochem J. 1998; 336 1-31
- 14 Consoli A, Nurjhan N, Capani F, Gerich J. Predominant role of gluconeogenesis in increased hepatic glucose production in NIDDM. Diabetes. 1989; 38 550-557
- 15 Hanson R W, Reshef L. Regulation of phosphoenolpyruvate carboxykinase (GTP) gene expression. Annual Review of Biochemistry. 1997; 66 581-611
- 16 Wiernsperger N, Bailey C. The antihyperglycaemic effect of metformin. Drugs. 1999; 58 (Suppl. 1) 31-39
- 17 Large V, Beylot M. Modifications of citric acid cycle activity and gluconeogenesis in streptozotocin-induced diabetes and effects of metformin. Diabetes. 1999; 48 1251-1257
- 18 Meyer F, Ipaktchi M, Clauser H. Specific inhibition of gluconeogenesis by biguanides. Nature. 1967; 213 203-204
- 19 Heber D, Yip I, Ashley J M, Elashoff D A, Elashoff R M, Go V L. Cholesterol-lowering effects of a proprietary Chinese red-yeast-rice dietary supplement. Am J Clin Nutr. 1999; 69 231-236
Prof. Juei-Tang Cheng
Department of Pharmacology · College of Medicine · National Cheng Kung University · Tainan City · Taiwan 70101, R.O.C.
Phone: +886 (6) 237-2706
Fax: +886 (6) 238-6548 ·
Email: jtcheng@mail.ncku.edu.tw